Protherics PLC 2008 Annual General Meeting Results London, UK; Brentwood, TN, US: 22 July 2008 - Protherics PLC (the"Company"), the international biopharmaceutical company focused on critical care and cancer, is pleased to announce that Resolutions 1 to 7 and 9 to 11 put forward at the Annual General Meeting of the Company held earlier today were passed. Since Resolution 7 was passed, Resolution 8 was withdrawn. The proxy figures for the Resolutions are set out below and will shortly be displayed on the Company's website at www.protherics.com. Resolution Number Shares For Shares Shares Shares Poll (as noted on proxy Discretionary Against Marked As Yes/ form) Votes No Withheld/ Abstentions 1 To receive the 227,968,493 616,122 349,378 1,776 No Financial Statements for the year ended 31 March 2007 together with the reports of the Directors and Auditors. 2 To elect R B 228,087,050 613,554 172,810 62,355 No Soderstrom as a Director. 3 To reappoint 228,114,010 624,117 190,689 6,953 No KPMG Audit Plc as Auditors of the Company. 4 To authorise 228,147,226 618,045 163,724 6,774 No the Directors to set the remuneration of the Auditors. 5 To approve the 152,200,073 610,805 59,894,074 16,230,817 No Directors' Remuneration Report for the year ended 31 March 2008. 6 To authorise 227,624,529 615,890 607,360 87,990 No the Directors to allot shares pursuant to Section 80 of the Companies Act 1985 (the"Act") 7 To authorise 220,212,918 627,390 3,747,064 4,348,397 No the Directors to disapply pre-emption rights pursuant to Section 95 of the Act (10%). 8 To authorise 228,076,114 622,456 143,951 93,248 No the Directors to disapply pre-emption rights pursuant to Section 95 of the Act (5%). 9 To receive and 228,004,502 639,725 189,939 101,603 No adopt the amended Articles of Association. 10 To approve and 228,181,154 625,467 97,992 31,156 No adopt the Protherics PLC 2008 Savings-Related Share Option Scheme. 11 To authorise 228,123,047 636,098 142,146 34,478 No the Directors to make amendments to the Protherics PLC 1996 unapproved Share Option Scheme The full text of the resolutions together with the related Circular to Shareholders can be viewed at: The Document Viewing Facility The Financial Services Authority 25 The North Colonnade Canary Wharf London E14 5HS / Ends / For further information please contact: Protherics Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510 Julie Vickers, Company Secretary +44 (0)1928 518000 Financial Dynamics - press enquiries London: Ben Atwell, Lara Mott +44 (0) 20 7831 3113 New York: John Capodanno +1 212 850 5600 Or visit www.protherics.com This information is provided by RNS The company news service from the London Stock Exchange END
Contact Information: Contacts: RNS Customer Services 0044-207797-4400 http://www.rns.com